Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.

For reference, Novo Nordisk also offers a highly successful weight loss drug, Wegovy, a GLP-1 receptor agonist.

The effect of Novo Nordisk’s amycretin injections on body weight showed no signs of plateauing after 36 weeks, suggesting the ...

INDIANAPOLIS, Ind. - Eli Lilly and Company, a major pharmaceutical company, announced on Monday that its weight-loss drug, ...

China’s nascent weight loss drug market is poised for rapid growth ... The Chinese company ran large clinical trials suggesting that in local patients, it appeared just as effective as Lilly’s ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

The World Health Organization continues its investigation into the origins of COVID-19, with significant information still ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

In combination with Eli Lilly’s tirzepatide, marketed as Zepbound for obesity, Scholar Rock’s monolonal antibody helped ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.